| GTO ID | GTC1441 |
| Trial ID | NCT01787994 |
| Disease | HIV Infection |
| Altered gene | MazF-T |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | MazF-T RTV CD4 cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I, Open Label, Dual Cohort, Single Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Autologous CD4 T Cells Modified With a Retroviral Vector Expressing the MazF Endoribonuclease Gene in Patients With HIV |
| Year | 2013 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | 815441 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||
|
|||||||